Font Size: a A A
Keyword [Parkinson’s Disease]
Result: 81 - 100 | Page: 5 of 10
81. Study Of Scalp Acupuncture On Parkinson’s Disease With The Chorea Trembling Control Area
82. IvNon-motor Symptoms In Patients With Essential Tremor And Parkinson’s Disease
83. Feasibility Studies On Non-Invasive Evaluation Of Parkinson’ Disease Using Dopamine Receptor Imaging Method
84. Regulation And The Underlying Mechanisms Of ASIC1a On Dopamine Release In The Nigrostriatal Pathway
85. DRAM1 Protects Against Rotenone-induced Dopaminergic Damage
86. Social Cognition Processes Are Impaired And Brain Functional Connectivity Alteration In Parkinson’s Disease
87. Autophagic Dysfunction Contributes To α-synuclein Accumulation In Rotenone-induced Parkinson’s Disease
88. Odor Identification Test In REM Sleep Behavior Disorder And Parkinson’s Disease
89. Clinical Heterogeneity And Its Relation With Cognitive Dysfunction In Patients With Parkinson’s Disease
90. NO Stress Regulates The Apoptosis In The Cells Of Parkinson’s Disease Paradigm
91. Study On The Neuroprotection And Its Mechanism Of Basic Fibroblast Growth Factor In The Model Of Parkinson’s Disease
92. Study Of Cognitive Neuropsychology In Parkinson’s Disease
93. Characteristics, Affecting Factors And Metabolomics Analysis Of Sleep Disorder In Parkinson’s Disease
94. The Study Of Clinical Features Of Early-onset Parkinson’s Disease And Gene Mutation Analysis Of PARKIN In Uyghur Family With Early-onset Parkinson’s Disease
95. The Study On Axonal Degeneration Of Nigra-striatum Dopaminergic Neurons From MPTP Toxicity
96. Expression Of TLR4 And Its Effects On Release Of Inflammatory Mediators In Midbrain In A MPTP Mouse Model Of Parkinson’ Disease
97. The Role Of CCL2 In The Pathogenesis Of Mild Cognitive Impairment In Parkinson’s Disease
98. Protective Effects And Mechanisms Of Rosmarinic Acid Against Rotenone-induced Parkinson’s Disease Models
99. Research On Mutations Of LRRK2 Gene And VPS35 Gene In PD Patients
100. Small Peptide Inhibitor Of JNK3 Protects Against MPP~+/MPTP Induced Dopaminergic Injury Via Inhibiting The ASK1/JNK3 Signaling Pathway
  <<First  <Prev  Next>  Last>>  Jump to